Imatinib mesylate (STI571) treatment in patients with chronic-phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation

  1. Cervantes, F.
  2. Hernández-Boluda, J.-C.
  3. Odriozola, J.
  4. Camós, M.
  5. Villalón, L.
  6. Martínez-Climent, J.-A.
  7. Del Campo, R.
  8. García-Conde, J.
  9. Montserrat, E.
Journal:
British Journal of Haematology

ISSN: 0007-1048

Year of publication: 2003

Volume: 120

Issue: 3

Pages: 500-504

Type: Article

DOI: 10.1046/J.1365-2141.2003.04077.X GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus